Clinical Trial Update: Trial to Evaluate L9LS in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the monoclonal antibody L9LS in healthy adults to assess safety and pharmacokinetics for malaria. The study has completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• L9LS

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2023-10-13